Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,265
Total Claims
$182K
Drug Cost
116
Beneficiaries
$1,565
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-64%
Opioid rate vs peers
0.8% vs 2.2% avg
+11%
Cost per patient vs peers
$1,565 vs $1,411 avg
+31%
Brand preference vs peers
14.0% vs 10.6% avg
Opioid Prescribing
0.8%
Opioid Rate
18
Opioid Claims
$171
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 309 claims · $147K
Generic: 1,905 claims · $31K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Aspart | 32 | $20K |
| Insulin Glargine/Lixisenatide | 19 | $18K |
| Empagliflozin | 18 | $16K |
| Dulaglutide | 13 | $13K |
| Apixaban | 12 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $7,506 |
| Rivaroxaban | 12 | $7,005 |
| Insulin Glargine,hum.Rec.Anlog | 14 | $5,169 |
| Insulin Lispro | 16 | $4,740 |
| Fluticasone Propion/Salmeterol | 11 | $3,946 |
| Insulin Glargine,hum.Rec.Anlog | 12 | $3,779 |
| Albuterol Sulfate | 66 | $2,823 |
| Atorvastatin Calcium | 139 | $1,516 |
| Hydralazine Hcl | 68 | $1,187 |
| Omeprazole | 82 | $971 |
Prescribing Profile
Patient Profile
67
Avg Age
53%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About